# Autologous OC-DC Vaccine in Ovarian Cancer

> **NCT01132014** · EARLY_PHASE1 · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 67 (actual)

## Conditions studied

- Chemotherapy
- Tumor
- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** OCDC

## Key facts

- **NCT ID:** NCT01132014
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2018-05-30
- **Final completion:** 2018-05-30
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2018-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01132014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01132014, "Autologous OC-DC Vaccine in Ovarian Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01132014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*